Aug 17, 2018
This podcast discusses the article "Lower Cardiovascular Risk Associated with SGLT-2i in >400,000 Patients: The CVD-REAL 2 Study." The multinational study explores real world evidence on the use of sodium-glucose cotransporter-2. As the incidence of type 2 diabetes mellitus rises in the United States, understanding...
Aug 6, 2018
This podcast discusses the risks and benefits of starting new diabetes therapies on a patient with type 2 diabetes. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug classes will prepare you to better treat your patients.
Jul 20, 2018
This podcast discusses monitoring patients who have been started on a new diabetes therapy, such as sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide 1 receptor agonists. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug...
Jul 6, 2018
This podcast discusses the article "Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis." As the incidence of type 2 diabetes mellitus rises in the United States, understanding the...
Jun 29, 2018
This podcast discusses new data pertaining to the class of SGLT2 inhibitors in the treatment of diabetes and its cardioprotective properties. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the results of the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in...